JP2003533537A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003533537A5 JP2003533537A5 JP2001585141A JP2001585141A JP2003533537A5 JP 2003533537 A5 JP2003533537 A5 JP 2003533537A5 JP 2001585141 A JP2001585141 A JP 2001585141A JP 2001585141 A JP2001585141 A JP 2001585141A JP 2003533537 A5 JP2003533537 A5 JP 2003533537A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- polysialic
- groups
- denaturing agent
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 description 25
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000002253 acid Substances 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 125000005629 sialic acid group Chemical group 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 125000001288 lysyl group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- -1 alkali metal salt Chemical class 0.000 description 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00304108.4 | 2000-05-16 | ||
| EP00304108 | 2000-05-16 | ||
| PCT/GB2001/002115 WO2001087922A2 (en) | 2000-05-16 | 2001-05-14 | Derivatisation of proteins in aqueous solution |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003533537A JP2003533537A (ja) | 2003-11-11 |
| JP2003533537A5 true JP2003533537A5 (enExample) | 2008-06-05 |
Family
ID=8172993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001585141A Pending JP2003533537A (ja) | 2000-05-16 | 2001-05-14 | タンパク質の誘導体化 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6962972B2 (enExample) |
| EP (1) | EP1335931B1 (enExample) |
| JP (1) | JP2003533537A (enExample) |
| AT (1) | ATE313554T1 (enExample) |
| AU (1) | AU2001258536A1 (enExample) |
| DE (1) | DE60116137T2 (enExample) |
| ES (1) | ES2256234T3 (enExample) |
| WO (1) | WO2001087922A2 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2294535T3 (es) | 2003-08-12 | 2008-04-01 | Lipoxen Technologies Limited | Derivados del acido polisialico. |
| EP1654290B1 (en) * | 2003-08-12 | 2019-03-13 | Lipoxen Technologies Limited | Sialic acid derivatives for protein derivatisation and conjugation |
| US8652334B2 (en) | 2004-08-12 | 2014-02-18 | Lipoxen Technologies Limited | Fractionation of charged polysaccharide |
| EP3184551A1 (en) | 2004-08-12 | 2017-06-28 | Lipoxen Technologies Limited | Sialic acid derivatives |
| TWI376234B (en) | 2005-02-01 | 2012-11-11 | Msd Oss Bv | Conjugates of a polypeptide and an oligosaccharide |
| US8217154B2 (en) | 2005-02-23 | 2012-07-10 | Lipoxen Technologies Limited | Activated sialic acid derivatives for protein derivatisation and conjugation |
| US8299015B2 (en) * | 2006-07-25 | 2012-10-30 | Lipoxen Technologies Limited | Derivatisation of granulocyte colony-stimulating factor |
| EP2409995A3 (en) | 2007-02-28 | 2012-08-15 | Lipoxen Technologies Limited | Reduction of endotoxin in polysialic acids |
| JP5909755B2 (ja) | 2009-07-27 | 2016-04-27 | リポクセン テクノロジーズ リミテッド | 非血液凝固タンパク質の糖ポリシアル酸化 |
| EP3093029A1 (en) * | 2009-07-27 | 2016-11-16 | Baxalta GmbH | Blood coagulation protein conjugates |
| CA2771999A1 (en) | 2009-08-24 | 2011-03-10 | Amunix Operating Inc. | Coagulation factor vii compositions and methods of making and using same |
| TR201908836T4 (tr) | 2010-07-30 | 2019-07-22 | Baxalta GmbH | Oksim bağına yönelik nükleofilik katalizörler. |
| JP2014520094A (ja) | 2011-05-27 | 2014-08-21 | バクスター・インターナショナル・インコーポレイテッド | 増加した半減期を有する治療用タンパク質およびそれを調製する方法 |
| US9486507B2 (en) | 2011-06-10 | 2016-11-08 | Biogen Ma Inc. | Pro-coagulant compounds and methods of use thereof |
| CN104271150A (zh) | 2012-01-12 | 2015-01-07 | 比奥根艾迪克Ma公司 | 嵌合因子viii多肽及其用途 |
| EP2822577B1 (en) | 2012-02-15 | 2019-02-06 | Bioverativ Therapeutics Inc. | Recombinant factor viii proteins |
| JP6256882B2 (ja) | 2012-02-15 | 2018-01-10 | アムニクス オペレーティング インコーポレイテッド | 第ｖｉｉｉ因子組成物、ならびに組成物の作製方法および用途 |
| AU2013204754C1 (en) | 2012-05-16 | 2018-10-11 | Takeda Pharmaceutical Company Limited | Nucleophilic Catalysts for Oxime Linkage |
| WO2013185113A1 (en) | 2012-06-08 | 2013-12-12 | Biogen Idec Ma Inc. | Procoagulant compounds |
| CA2875247A1 (en) | 2012-06-08 | 2013-12-12 | Biogen Idec Ma Inc. | Chimeric clotting factors |
| CN104661674A (zh) | 2012-07-11 | 2015-05-27 | 阿穆尼克斯运营公司 | 具有xten和血管性血友病因子蛋白的因子viii复合物、及其用途 |
| CN113817069A (zh) | 2013-06-28 | 2021-12-21 | 比奥贝拉蒂治疗公司 | 具有xten的凝血酶可裂解连接子和其用途 |
| TW202003554A (zh) | 2013-08-14 | 2020-01-16 | 美商百歐維拉提夫治療公司 | 因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途 |
| HUE057005T2 (hu) | 2013-09-25 | 2022-04-28 | Bioverativ Therapeutics Inc | Oszlopon történõ vírusinaktiváló eljárások |
| EP3065769A4 (en) | 2013-11-08 | 2017-05-31 | Biogen MA Inc. | Procoagulant fusion compound |
| AU2015204646B2 (en) | 2014-01-10 | 2020-08-27 | Bioverativ Therapeutics Inc. | Factor VIII chimeric proteins and uses thereof |
| WO2015130963A2 (en) | 2014-02-27 | 2015-09-03 | Xenetic Biosciences, Inc. | Compositions and methods for administering insulin or insulin-like protein to the brain |
| CU20170038A7 (es) | 2014-09-26 | 2017-10-05 | Bayer Pharma AG | Derivados de adrenomedulina estabililzados especialmente útiles en el tratamiento y/o prevención de trastornos cardiovasculares, edematosos y/o inflamatorios |
| BR112017007765B1 (pt) | 2014-10-14 | 2023-10-03 | Halozyme, Inc | Composições de adenosina deaminase-2 (ada2), variantes do mesmo e métodos de usar o mesmo |
| MA40835A (fr) | 2014-10-23 | 2017-08-29 | Biogen Ma Inc | Anticorps anti-gpiib/iiia et leurs utilisations |
| MA40861A (fr) | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | Anticorps anti-glycoprotéines iib/iiia |
| EA201890423A1 (ru) | 2015-08-03 | 2018-07-31 | Биовератив Терапьютикс Инк. | Слитые белки фактора ix, способы их получения и применения |
| SG11201804666QA (en) | 2015-12-03 | 2018-06-28 | Baxalta Inc | Factor viii with extended half-life and reduced ligand-binding properties |
| BR112018070459A2 (pt) | 2016-04-04 | 2019-02-12 | Shire Human Genetic Therapies, Inc. | inibidor da c1 esterase conjugado e usos do mesmo |
| PE20210313A1 (es) | 2018-03-28 | 2021-02-12 | Bristol Myers Squibb Co | Proteinas de fusion interleucina-2/receptor alfa de interleucina-2 y metodos de uso |
| PL3793588T3 (pl) | 2018-05-18 | 2025-09-01 | Bioverativ Therapeutics Inc. | Sposoby leczenia hemofilii a |
| KR20210027426A (ko) | 2018-07-03 | 2021-03-10 | 브리스톨-마이어스 스큅 컴퍼니 | Fgf21 제제 |
| EP3986918A1 (en) | 2019-06-18 | 2022-04-27 | Bayer Aktiengesellschaft | Adrenomedullin-analogues for long-term stabilization and their use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356170A (en) * | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| US4727136A (en) * | 1985-10-01 | 1988-02-23 | Canadian Patents And Development Ltd. | Modified meningococcal group B polysaccharide for conjugate vaccine |
| GB9112212D0 (en) | 1991-06-06 | 1991-07-24 | Gregoriadis Gregory | Pharmaceutical compositions |
| US5846951A (en) * | 1991-06-06 | 1998-12-08 | The School Of Pharmacy, University Of London | Pharmaceutical compositions |
| US5951974A (en) * | 1993-11-10 | 1999-09-14 | Enzon, Inc. | Interferon polymer conjugates |
| US5738846A (en) * | 1994-11-10 | 1998-04-14 | Enzon, Inc. | Interferon polymer conjugates and process for preparing the same |
| US5705364A (en) | 1995-06-06 | 1998-01-06 | Genentech, Inc. | Mammalian cell culture process |
-
2001
- 2001-05-14 DE DE60116137T patent/DE60116137T2/de not_active Expired - Lifetime
- 2001-05-14 EP EP01931843A patent/EP1335931B1/en not_active Expired - Lifetime
- 2001-05-14 AT AT01931843T patent/ATE313554T1/de not_active IP Right Cessation
- 2001-05-14 US US10/276,552 patent/US6962972B2/en not_active Expired - Lifetime
- 2001-05-14 WO PCT/GB2001/002115 patent/WO2001087922A2/en not_active Ceased
- 2001-05-14 ES ES01931843T patent/ES2256234T3/es not_active Expired - Lifetime
- 2001-05-14 JP JP2001585141A patent/JP2003533537A/ja active Pending
- 2001-05-14 AU AU2001258536A patent/AU2001258536A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003533537A5 (enExample) | ||
| Urrutia et al. | Use of chitosan heterofunctionality for enzyme immobilization: β-galactosidase immobilization for galacto-oligosaccharide synthesis | |
| JPS6121227B2 (enExample) | ||
| US7306931B2 (en) | Method for refolding proteins containing free cysteine residues | |
| JP2975632B2 (ja) | グリコサミノグリカン修飾プロテイン | |
| TWI325430B (en) | Aminated complex type sugar chain derivative and its production method | |
| US20240083945A1 (en) | Anti-infective bicyclic peptide ligands | |
| CN105593238B (zh) | 使用微生物转谷氨酰胺酶进行赖氨酸特异性化学酶法蛋白质修饰 | |
| WO2001087922A3 (en) | Derivatisation of proteins in aqueous solution | |
| TWI268279B (en) | Dimeric anti-viral agents and methods for preparation and use thereof | |
| JP2007529536A5 (enExample) | ||
| JP2009544681A5 (enExample) | ||
| CA2446619A1 (en) | Permeation enhancers | |
| JPH09504515A (ja) | ポリマー変性 | |
| WO2002077195A3 (en) | Plasmodium falciparum ama-1 protein and uses thereof | |
| PT751144E (pt) | Novos pro-farmacos antraciclinicos, metodo para preparacao e tambem a sua utilizacao em quimioterapia selectiva | |
| JP2018035192A5 (enExample) | ||
| US20120178914A1 (en) | Polypeptide modification | |
| CY1111165T1 (el) | Μειγματα ολιγοσακχαριτων που προερχονται απο την ηπαρινη, η παρασκευη τους και οι φαρμακευτικες ενωσεις που τα περιεχουν | |
| WO1999021588A1 (en) | Heparin-binding growth factor derivatives | |
| CA2439337A1 (en) | Highly sulfated derivatives of k5 polysaccharide and their preparation | |
| Levesque et al. | Protein thioacylation. 1. Reagents design and synthesis | |
| EP0242301B1 (fr) | Procédé de purification d'antigènes protéiques de bactéries appartenant au genre Bordetella, en vue de l'obtention d'un vaccin acellulaire | |
| EP1137442B1 (en) | Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative | |
| WO1998051780A3 (en) | Method for increasing yields or recombinant proteins |